EPAS1 and somatostatinoma: For example, a considerable fraction of patients exhibited somatostatinomas along with mutations in the HIF2A gene [44, 124] and approximately a half of those with HIF2α-mutant tumors demonstrated the early development of polycythemia [42, 124].